Want to see ZBIO full AI Analyst Report?
Zenas BioPharma, Inc. (ZBIO) Ownership Overview
16.65% Insiders
29.04% Mutual Funds
0.13% Other Institutional Investors
9.37% ETFs
44.81% Public Companies and
Individual Investors
The ownership structure of Zenas BioPharma, Inc. (ZBIO) stock is a mix of institutional, retail, and individual investors. Approximately 38.54% of the company’s stock is owned by Institutional Investors, 16.65% is owned by Insiders, and 44.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 18, 2026 | xxxxxxxxxxxxx | $1012800 | |
Apr 29, 2026 | xxxxxxxxxxxxx | $1067200 | |
Apr 02, 2026 | xxxxxxxxxxxxx | $70198 | |
Apr 01, 2026 | xxxxxxxxxxxxx | $3000000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $14987880 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $68176391 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,119,959 | Insider | 4.79% | 88,575,636 | |
| 2,937,055 | Institution | 4.51% | 83,382,991 | |
| 2,619,189 | Insider | 4.02% | 74,358,776 | |
| 2,434,000 | Institution | 3.73% | 69,101,260 | |
| 2,359,025 | Institution | 3.62% | 66,972,720 | |
| 2,359,025 | Insider | 3.62% | 66,972,720 | |
| 2,306,122 | Insider | 3.54% | 65,470,804 | |
| 2,227,000 | Institution | 3.42% | 63,224,530 | |
| 2,066,663 | Institution | 3.17% | 58,672,563 | |
| 1,911,091 | Institution | 2.93% | 54,255,873 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,937,055 | Institution | 4.51% | 83,382,991 | |
| 2,434,000 | Institution | 3.73% | 69,101,260 | |
| 2,227,000 | Institution | 3.42% | 63,224,530 | |
| 1,911,091 | Institution | 2.93% | 54,255,873 | |
| 1,460,400 | Institution | 2.24% | 41,460,756 | |
| 1,326,708 | Institution | 2.04% | 37,665,240 | |
| 1,112,983 | Institution | 1.71% | 31,597,587 | |
| 1,064,191 | Institution | 1.63% | 30,212,382 | |
| 991,724 | Institution | 1.52% | 28,155,044 | |
| 662,841 | Institution | 1.02% | 18,818,056 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,166,396 | Institution | 1.79% | 31,457,700 | |
| 1,093,126 | Institution | 1.68% | 31,449,235 | |
| 905,744 | Institution | 1.39% | 26,058,255 | |
| 515,945 | Institution | 0.79% | 13,915,037 | |
| 337,463 | Institution | 0.52% | 9,705,436 | |
| 267,136 | Institution | 0.41% | 7,682,831 | |
| 241,719 | Institution | 0.37% | 6,954,256 | |
| 209,607 | Institution | 0.32% | 5,653,101 | |
| 127,391 | Institution | 0.20% | 3,663,765 | |
| 109,613 | Institution | 0.17% | 3,153,566 |
FAQ
Who Owns Zenas BioPharma, Inc. (ZBIO)?
According to the latest TipRanks data, approximately 0.13% of the company's stock is held by institutional investors, 16.65% is held by insiders, and 44.81% is held by retail investors.
What percentage of Zenas BioPharma, Inc. (ZBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.13% of Zenas BioPharma, Inc. (ZBIO) stock is held by institutional investors.
What percentage of Zenas BioPharma, Inc. (ZBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.81% of Zenas BioPharma, Inc. (ZBIO) stock is held by retail investors.
Who owns the most shares of Zenas BioPharma, Inc. (ZBIO)?
Jason Raleigh Nunn owns the most shares of Zenas BioPharma, Inc. (ZBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.